Electroacupuncture Combined With PD-1 Inhibitor for Elderly Patients With Advanced NSCLC

NARecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

July 8, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2028

Conditions
Elderly Patients (>65 Years)Non-Small Cell Lung CancerPD-1 InhibitorsElectroacupuncture
Interventions
OTHER

Electroacupuncture (EA)

"In the electroacupuncture group, bilateral Zusanli (ST36) and Sanyinjiao (SP6) points were selected for needling. Upon achieving the deqi sensation, the electroacupuncture device was connected to the needles at both points. A dispersed-dense wave was applied with an intensity ranging from 0.5 to 2 mA, adjusted according to the patient's tolerance. The needles were retained for 20 minutes, after which they were removed."

OTHER

Sham electroacupuncture

"In the sham electroacupuncture group, bilateral Zusanli (ST36) and Sanyinjiao (SP6) points were selected for sham electroacupuncture intervention, which did not receive manual manipulation. The electrode placement and other treatment settings were identical to those in the electroacupuncture group, but no skin penetration, electrical output, or needle techniques were applied to induce the sensation of deqi. No genuine electroacupuncture stimulation was administered in this group."

Trial Locations (1)

300193

RECRUITING

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin

All Listed Sponsors
lead

Kong Fanming

OTHER

NCT07086300 - Electroacupuncture Combined With PD-1 Inhibitor for Elderly Patients With Advanced NSCLC | Biotech Hunter | Biotech Hunter